Navigation Links
Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
Date:1/16/2008

AUSTIN, Texas, Jan. 16 /PRNewswire-USNewswire/ -- Start Licensing, Inc. ("Start"), a joint venture of Geron Corporation (Nasdaq:) and Exeter Life Sciences supports the final risk assessment released by the US Food and Drug Administration on January 15. The assessment concluded that meat and dairy products from animal clones and their offspring are safe for human consumption.

"FDA's conclusion is consistent with a report released January 11, 2008 by the European Food Safety Authority and studies in other countries. These findings open the door to widespread adoption of the technology platform to enhance the quality of meat and dairy products" said Jonathan Thatcher, president of Start. "With this safety conclusion, ranchers and livestock producers can look to cloning technology to rapidly increase the best genetics, including quality and health traits, in their herds."

Created in 2005, Start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a worldwide portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology developed at the Roslin Institute. The nuclear transfer patents managed by Start have been upheld by the US PTO in three separate patent interference proceedings and in opposition proceedings by patent offices in other countries. Start's licensees are engaged in research and product development in food production, medical applications and other fields.

For more information call Natalie Garrett, Start Licensing/Turner Strategies, 202-466-9633


'/>"/>
SOURCE Start Licensing, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Visiprise Manufacturing Wins START-IT Top 50 Technologies Award
3. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
4. Optherion, Inc. Completes $37 Million Start Up Financing
5. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
8. SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
9. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
10. Industry Executives Finding Value in Shift of Scientific Publications
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 2017 The Global Implantable Biomaterials Market ... around 7.5% over the next decade to reach ... prominent trends that the market is witnessing include ... graft transplant surgeries and medical implants and technological ... categorized into immunomodulatory biomaterials, natural, polymers, hydrogels and ...
(Date:1/17/2017)... , Jan. 17, 2017  Zimmer Biomet Holdings, ... quarter and full-year 2016 sales and earnings conference call ... January 31, 2017, at 8 a.m. Eastern Time.  A ... be made available at 7:30 a.m. Eastern Time the ... audio webcast can be accessed via Zimmer Biomet,s Investor ...
(Date:1/17/2017)... Jan. 17, 2017 Research and Markets ... "Molecular Diagnostics - Technologies, Markets and Companies" to their ... ... increased remarkably during the past few years. More than 1,000 ... diagnostics and 342 of these are profiled in the report ...
(Date:1/17/2017)... Cleveleys, UK (PRWEB) , ... ... ... results presented by surgeons at the 2016 annual meeting of the North ... beneficial clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ ...
Breaking Biology Technology:
(Date:1/12/2017)... 12, 2017  New research undertaken by Fit Small ... future.  1,000 participants were simply asked which office technology had ... may consider standard issue.  Insights on what will ... gathered from futurists and industry leaders including Penelope Trunk ... .  Some of these findings ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
Breaking Biology News(10 mins):